AGREEMENT ON PROVISION OF SERVICES AND PREMISES FOR EXECUTION OF CLINICAL STUDYSmlouva O Poskytnutí Služeb a Prostor K Provedení Klinického Hodnocení • September 7th, 2018
This Agreement on Provision of Services and Premises for Execution of Clinical Study (“Agreement”) is effective as of the date of publication in the Register of Contracts (“Effective Date”) between Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, Massachusetts 02210 USA, Company registration number [Tax ID: 043039129] as represented by Mary-Lynn Fulton, Senior Director, Study Management, appointing as its legal representative in the EU with regard to liability (art. 19 EU Directive 2001/83) Vertex Pharmaceuticals (Europe) Limited, with the registered office at 2 Kingdom Street, London, W2 6BD, United Kingdom
